ELOVL Fatty Acid Elongase 5 (ELOVL5) Peptide
ELOVL5
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN976309
Quick Overview for ELOVL Fatty Acid Elongase 5 (ELOVL5) Peptide (ABIN976309)
Target
ELOVL5
(ELOVL Fatty Acid Elongase 5 (ELOVL5))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ELOVL5 antibody (Catalog #: ARP49667_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ELOVL5 (ELOVL Fatty Acid Elongase 5 (ELOVL5))
-
Background
-
ELOVL5 plays a role in elongation of long-chain polyunsaturated fatty acids.ELOVL5 plays a role in elongation of long-chain polyunsaturated fatty acids (Leonard et al., 2000 [PubMed 10970790]).[supplied by OMIM]. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-3003 AF338241.1 9-3011
Alias Symbols: HELO1, RP3-483K16.1, dJ483K16.1
Protein Size: 299 -
Molecular Weight
- 35 kDa
-
Gene ID
- 60481
-
NCBI Accession
- NM_021814, NP_068586
-
UniProt
- Q9NYP7
Target
-
You are here:
